Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
3.75
-0.15 (-3.85%)
At close: Aug 19, 2025, 3:59 PM
3.82
1.87%
After-hours: Aug 19, 2025, 05:06 PM EDT
Galectin Therapeutics Revenue
Galectin Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Galectin Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
15
Market Cap
240.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 0 | n/a |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |
Dec 31, 2019 | 0 | n/a |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |
Dec 31, 2016 | 0 | n/a |
Dec 31, 2015 | 0 | n/a |
Dec 31, 2014 | 0 | n/a |
Dec 31, 2013 | 0 | n/a |
Dec 31, 2012 | 0 | n/a |
Dec 31, 2011 | 0 | n/a |
Dec 31, 2010 | 0 | n/a |
Dec 31, 2009 | 0 | n/a |
Dec 31, 2008 | 0 | n/a |
Dec 31, 2007 | 0 | n/a |
Dec 31, 2006 | 0 | n/a |
Dec 31, 2005 | 0 | n/a |
Dec 31, 2004 | 0 | n/a |
Dec 31, 2003 | 0 | n/a |
Dec 31, 2002 | 0 | n/a |
Dec 31, 2001 | 0 | n/a |
Dec 31, 2000 | 0 | n/a |